A detailed history of Massmutual Trust CO Fsb transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 45 shares of PCRX stock, worth $789. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 210 78.57%
Holding current value
$789
Previous $6,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$11.7 - $28.46 $1,930 - $4,695
-165 Reduced 78.57%
45 $0
Q2 2024

Jul 02, 2024

SELL
$25.5 - $31.51 $2,371 - $2,930
-93 Reduced 30.69%
210 $6,000
Q1 2024

Apr 09, 2024

BUY
$27.7 - $35.48 $415 - $532
15 Added 5.21%
303 $8,000
Q4 2023

Jan 03, 2024

BUY
$26.32 - $34.31 $6,685 - $8,714
254 Added 747.06%
288 $9,000
Q3 2023

Oct 03, 2023

SELL
$30.68 - $40.09 $2,699 - $3,527
-88 Reduced 72.13%
34 $1,000
Q2 2023

Aug 01, 2023

BUY
$36.12 - $47.5 $577 - $760
16 Added 15.09%
122 $4,000
Q1 2023

Apr 11, 2023

BUY
$35.53 - $43.38 $106 - $130
3 Added 2.91%
106 $4,000
Q4 2022

Jan 06, 2023

BUY
$38.19 - $57.45 $2,520 - $3,791
66 Added 178.38%
103 $4,000
Q3 2022

Oct 07, 2022

BUY
$51.24 - $58.89 $153 - $176
3 Added 8.82%
37 $2,000
Q2 2022

Jul 07, 2022

SELL
$51.49 - $81.64 $308 - $489
-6 Reduced 15.0%
34 $2,000
Q1 2022

Apr 08, 2022

BUY
$60.03 - $76.49 $1,740 - $2,218
29 Added 263.64%
40 $3,000
Q4 2021

Feb 09, 2022

SELL
$47.97 - $62.21 $27,007 - $35,024
-563 Reduced 98.08%
11 $1,000
Q4 2017

Feb 21, 2018

SELL
$31.85 - $46.95 $164,409 - $242,355
-5,162 Reduced 89.99%
574 $8.39 Million
Q3 2017

Feb 13, 2018

BUY
$35.7 - $39.5 $9,210 - $10,191
258 Added 4.71%
5,736 $215 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,478
5,478 $261 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $804M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Massmutual Trust CO Fsb Portfolio

Follow Massmutual Trust CO Fsb and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Massmutual Trust CO Fsb with notifications on news.